Skip to main content
Equibles
RLAY logo

RLAY · Relay Therapeutics, Inc.

Track RLAY — free

Use RLAY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RLAY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.77 -0.65 (-3.35%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$4.12B
Shares
219.14M

Relay Therapeutics, Inc. Earnings Call Transcripts

Quarterly earnings calls for Relay Therapeutics, Inc. (RLAY), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $952,000 −$42.18M '21 Q1 21-04-16 ▼56.8% $365,000 −$76.79M '22 Q2 22-08-04 · $7.00M −$54.89M '25 Q4 26-03-25 ▼60.9% $3.00M −$73.29M '26 Q1 26-05-05 LATEST ▼48.3% $350,000 −$83.71M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Relay Therapeutics, Inc. (RLAY) Q2 2026 Earnings Call Transcript
Confident tone Zovega in second-line HR+/HER2- breast cancer Dose selection and PK interactions Frontline triplet with atirmociclib
Revenue
$350,000
▼ 48.3% YoY
Diluted EPS
$-0.41
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Relay Therapeutics, Inc. (RLAY) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Relay Therapeutics, Inc. (RLAY) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-19
Relay Therapeutics, Inc. (RLAY) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Relay Therapeutics, Inc. (RLAY) Q1 2026 Earnings Call
Revenue
$3.00M
▼ 60.9% YoY
Diluted EPS
$-0.41
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-27
Relay Therapeutics, Inc. (RLAY) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-25
Relay Therapeutics, Inc. (RLAY) Q4 2025 Earnings Call
Revenue
$7.00M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-11
Relay Therapeutics, Inc. (RLAY) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY22 · Q2
2022-08-04
Relay Therapeutics, Inc. (RLAY) Q2 2022 Earnings Call
Revenue
$365,000
▼ 56.8% YoY
Diluted EPS
$-0.71
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-16
Relay Therapeutics, Inc. (RLAY) Q1 2021 Earnings Call
Revenue
$952,000
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 earnings calls
Key facts CIK 1812364 CUSIP 75943R102 13F (30d) 239 filings 230 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)